The expression of SLC26A8 significantly correlated with fructose and mannose metabolism, galactose metabolism, glycine, serine and threonine metabolism, inflammatory bowel disease, nicotine addiction, porphyrin metabolism, starch and sucrose metabolism, systemic lupus erythematosus, taste transduction, TNF signaling pathway. Here, SLC26A8 is linked to inflammatory bowel disease.